Medicare Enrolled
Dr. Ramin Farshi, M.D.
Cardiovascular Disease · West Hills, CA
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Farshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Farshi
Dr. Ramin Farshi is a cardiovascular disease specialist in West Hills, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Farshi performed 11,026 Medicare services across 4,065 unique beneficiaries.
Between the years covered by Open Payments, Dr. Farshi received a total of $11,582 from 47 pharmaceutical and/or device companies across 558 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Farshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in CA
$11,582 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,026
Medicare services
Top 6% in CA for cardiovascular disease
4,065
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~551 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
2,320 | $42 | $65 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,872 | $46 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,851 | $102 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
999 | $67 | $100 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
512 | $43 | $300 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
497 | $34 | $60 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
495 | $12 | $65 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
392 | $61 | $180 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
343 | $173 | $710 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
272 | $144 | $300 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
199 | $21 | $60 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
198 | $395 | $1,200 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
154 | $178 | $350 |
| New patient office visit, complex (60-74 min) | 107 | $175 | $425 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
79 | $24 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
76 | $150 | $250 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
72 | $55 | $290 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
61 | $18 | $40 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
58 | $791 | $1,200 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
57 | $22 | $250 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
50 | $173 | $350 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
44 | $173 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
43 | $100 | $167 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
32 | $60 | $120 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
30 | $18 | $75 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
30 | $12 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $62 | $150 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
25 | $10 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $133 | $368 |
| Cardiac catheterization | 19 | $217 | $1,255 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $243 | $350 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
17 | $46 | $175 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
17 | $22 | $175 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
16 | $208 | $800 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
11 | $10 | $100 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
11 | $20 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
12.3% medium
83.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,582
Total received (2018-2024)
Avg $1,655/year across 7 years
Top 25% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
558
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,535 (99.6%)
Other
Charitable contributions, space rental, and other categories
$48 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,789
2023
$1,375
2022
$1,768
2021
$1,566
2020
$563
2019
$1,862
2018
$2,659
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$235
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$182
Novartis Pharmaceuticals Corporation
$177
E.R. Squibb & Sons, L.L.C.
$169
Amgen Inc.
$168
Merck Sharp & Dohme LLC
$144
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
Kiniksa Pharmaceuticals International, plc
$115
Medtronic, Inc.
$68
Janssen Pharmaceuticals, Inc
$61
Boston Scientific Corporation
$60
CVRx, Inc.
$56
Lexicon Pharmaceuticals, Inc.
$54
AstraZeneca Pharmaceuticals LP
$47
Novo Nordisk Inc
$34
iRhythm Technologies, Inc.
$26
Esperion Therapeutics, Inc.
$20
Abbott Laboratories
$19
Alnylam Pharmaceuticals Inc.
$19
Top 3 companies account for 33.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,627
Abbott Laboratories
$1,578
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,126
Boston Scientific Corporation
$941
Amgen Inc.
$899
PFIZER INC.
$646
E.R. Squibb & Sons, L.L.C.
$436
Medtronic Vascular, Inc.
$435
AstraZeneca Pharmaceuticals LP
$344
Janssen Pharmaceuticals, Inc
$338
Boehringer Ingelheim Pharmaceuticals, Inc.
$335
Merck Sharp & Dohme LLC
$302
SANOFI-AVENTIS U.S. LLC
$294
Amarin Pharma Inc.
$278
Gilead Sciences, Inc.
$202
Medtronic, Inc.
$153
ABIOMED
$150
GE HEALTHCARE
$125
BIOTRONIK INC.
$116
Kiniksa Pharmaceuticals International, plc
$115
Novo Nordisk Inc
$96
CVRx, Inc.
$88
Kiniksa Pharmaceuticals, Ltd.
$87
Biosense Webster, Inc.
$87
Alnylam Pharmaceuticals Inc.
$73
Resmed Corp
$61
Kestra Medical Technology Services, Inc.
$59
Lexicon Pharmaceuticals, Inc.
$54
Kowa Pharmaceuticals America, Inc.
$48
Baxter Healthcare
$48
PORTOLA PHARMACEUTICALS, INC.
$46
iRhythm Technologies, Inc.
$44
Lundbeck LLC
$44
Esperion Therapeutics, Inc.
$42
HeartFlow, Inc.
$39
Braemar Manufacturing, LLC
$30
Edwards Lifesciences Corporation
$28
ACIST MEDICAL SYSTEMS, INC.
$22
Actelion Pharmaceuticals US, Inc.
$22
Shockwave Medical, Inc
$20
Vertiflex, Inc.
$20
Relypsa, Inc.
$19
Acist Medical Systems, Inc.
$15
CARDIVA MEDICAL, INC.
$14
Regeneron Healthcare Solutions, Inc.
$13
Tactile Systems Technology Inc
$12
Bardy Diagnostics, Inc.
$11
Top 3 companies account for 37.4% of all-time payments
Associated products mentioned in payments ›
AIR 11 · ANDEXXA · AVEIR · AZURE XT DR MRI SURESCAN · Allure CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · BEVYXXA · BRILINTA · BYDUREON · Barostim Neo System · BodyGuardian · CAMZYOS · Cardiac Monitoring Suite · Cardiva VASCADE MVP VVCS 6-12F · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · ClosureFast · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FLEXITOUCH · FORTIFY ASSURA · Fortify Assura · GENERAL VASCULAR ACCESS · General - Therapies · General - Vascular Intervention · Impella · JARDIANCE · JOT DX · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · Optisure Defibrillation ICD Lead · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Perclose ProStyle · QUARTET · Quadra Assura CRT Defibrillator · REVEAL LINQ · RXI SYSTEMS · RXi Consumables · Repatha · Reprocessing · Reveal LINQ · Rybelsus · Superion ISS · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · Veltassa · WATCHMAN · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
386
Per 100K population
3.9
County median income
$87,760
Nearest hospital
UCLA WEST VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Farshi is a remote monitoring specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Farshi experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Farshi performed 2,320 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farshi receive payments from pharmaceutical companies?
Yes. Dr. Farshi received a total of $11,582 from 47 companies across 558 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farshi's costs compare to other cardiologists in West Hills?
Dr. Farshi's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in West Hills
Browse cardiologists in West Hills ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology